Shares of SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) climbed 2.7%, building on a previous gain of 2%, following the FDA approval of their drug, GOMEKLI, for the treatment of neurofibromatosis type ...
The dominance of the Magnificent Seven stocks may be fading as investors broaden their focus beyond Big Tech. While the group ...
RBC Capital analyst Nik Modi reiterated a Hold rating on PepsiCo (PEP – Research Report) today and set a price target of $164.00. The company’s ...
President Donald Trump’s pick to represent Northwest Florida in Congress soundly defeated his opponents Tuesday night. The Associated Press called the race for Florida's First Congressional District ...
CEO Albert Bourla says Pfizer has met the strategic goals it had set for itself in 2024, and that it was ‘executing transformative changes.’ ...
Palantir stock surges as artificial-intelligence gains drive an earnings and revenue beat, while China begins an antitrust ...
President Donald Trump’s pick to represent Northwest Florida in Congress soundly defeated his opponents Tuesday night. The Associated Press called the race for Florida's First Congressional ...